临床路径在慢性阻塞性肺疾病治疗中的应用

Application of clinical pathway in patients with chronic obstructive pulmonary disease

目的评价慢性阻塞性肺疾病（COPD）患者应用临床路径（cv）的可行性。方法选择确诊COPD的患者61例，随机分为实施CP管理组（试验组）和实施传统医疗护理组（对照组），观察两组患者住院费用、住院时间、满意度及心理变化。采用焦虑自评量表（SAS）、抑郁自评量表（SDS）测试患者入院时及出院时的心理变化。出院时采用满意度调查表进行满意度调查。结果试验组住院总费用、西药费、住院时间均明显低于对照组（P〈0．01），试验组出院前SAS、SDS积分均较入院时和对照组明显降低（P〈0．01），患者满意率亦高于对照组（P〈0．01）。结论临床路径应用于COPD可明显降低医疗费用，缩短住院时间，减少患者心理问题，提高患者的满意度，是一种行之有效、值得推广的服务管理模式。

Objective To evaluate the feasibility of application of the clinical pathway （CP） in patients with chronic obstructive pulmonary disease. Methods Sixty-one cases of chronic obstructive pulmonary disease were chosen. All the patients were randomly divided into two groups： 35 cases in clin- ical path administration group（ test group） and 26 cases in traditional medicine group （control group ）. Hospitalization expenses, hospitalization time, the psychological changes of the patient, faction degree were recorded. The psychological changes of the patients were detected by patients＇ satis-self-rating anxi-ety scale （SAS） and self-rating depression scale （SDS）. Results The total hospitalization expenses, the western medicine expenses, and the hospitalization time was significantly shorter in test group than that in control group. SAS and SDS scales decreased significantly in test group, compared to those in contrast group. Patients were more satisfied with their treatments in the test group. Conclusions Application of clinical pathway in the chronic obstructive pulmonary disease patients can obviously reduce expenses, hospitalization time, and psychological problems. And it can increase the satisfaction degree of patients. It is a new and effective management mode.